Positive Trial Results For Human Genome
June 11, 2009 at 13:41 PM EDT
Human Genome Sciences (Nasdaq: HGSI) announced positive results for its drug candidate in reducing symptoms of lupus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.